{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:26:28Z","timestamp":1783077988140,"version":"3.54.6"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31502030"],"award-info":[{"award-number":["31502030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81804013"],"award-info":[{"award-number":["81804013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virus Eradication"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jve.2021.100047","type":"journal-article","created":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T01:25:14Z","timestamp":1622337914000},"page":"100047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antiviral strategies targeting herpesviruses"],"prefix":"10.1016","volume":"7","author":[{"given":"Haisi","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jve.2021.100047_bib1","article-title":"herpesviruses","author":"Thomas","year":"2019","journal-title":"Diseases of Swine"},{"key":"10.1016\/j.jve.2021.100047_bib2","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1099\/vir.0.83045-0","article-title":"Discovery of herpesviruses in bats","volume":"88","author":"Wibbelt","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jve.2021.100047_bib3","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1128\/JVI.79.12.7609-7616.2005","article-title":"Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway","volume":"79","author":"Nicola","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jve.2021.100047_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003941","article-title":"CIB1 synergizes with EphrinA2 to regulate Kaposi's sarcoma-associated herpesvirus macropinocytic entry in human microvascular dermal endothelial cells","volume":"10","author":"Bandyopadhyay","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jve.2021.100047_bib5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1083\/jcb.200509155","article-title":"A novel role for phagocytosis-like uptake in herpes simplex virus entry","volume":"174","author":"Clement","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jve.2021.100047_bib6","first-page":"651691","article-title":"Nonprofessional phagocytosis can facilitate herpesvirus entry into ocular cells","author":"Tiwari","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jve.2021.100047_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00278-11","article-title":"Herpesvirus replication compartments originate with single incoming viral genomes","volume":"2","author":"Kobiler","year":"2011","journal-title":"mBio"},{"key":"10.1016\/j.jve.2021.100047_bib8","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.3390\/v7092861","article-title":"Tegument assembly and secondary envelopment of alphaherpesviruses","volume":"7","author":"Owen","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.jve.2021.100047_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jviromet.2014.05.022","article-title":"In vitro inhibition of Cyprinid herpesvirus-3 replication by RNAi","volume":"206","author":"Gotesman","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jve.2021.100047_bib10","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/jmv.24578","article-title":"Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools","volume":"88","author":"Paavilainen","year":"2016","journal-title":"J Med Virol"},{"key":"10.1016\/j.jve.2021.100047_bib11","first-page":"383","article-title":"Inhibition of herpesvirus-6B RNA replication by short interference RNAs","volume":"37","author":"Yoon","year":"2004","journal-title":"J Biochem Mol Biol"},{"key":"10.1016\/j.jve.2021.100047_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1517\/14712598.2015.1036736","article-title":"The therapeutic application of CRISPR\/Cas9 technologies for HIV","volume":"15","author":"Saayman","year":"2015","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.jve.2021.100047_bib13","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1128\/JVI.78.10.5147-5156.2004","article-title":"Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry","volume":"78","author":"Yasin","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jve.2021.100047_bib14","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1128\/JVI.76.22.11236-11244.2002","article-title":"Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry","volume":"76","author":"Herold","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jve.2021.100047_bib15","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/AAC.48.6.2025-2036.2004","article-title":"Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread","volume":"48","author":"Cheshenko","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jve.2021.100047_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2010.01.032","article-title":"Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain","volume":"400","author":"Adamiak","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jve.2021.100047_bib17","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1128\/JVI.00377-12","article-title":"Aptamer that binds to the gD protein of herpes simplex virus 1 and efficiently inhibits viral entry","volume":"86","author":"Gopinath","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jve.2021.100047_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.omtn.2017.10.009","article-title":"Targeting herpes simplex virus-1 gD by a DNA aptamer can be an effective new strategy to curb viral infection","volume":"9","author":"Yadavalli","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jve.2021.100047_bib19","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1128\/jvi.64.3.1348-1352.1990","article-title":"Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection","volume":"64","author":"Nemerow","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.jve.2021.100047_bib20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41564-018-0155-1","article-title":"Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry (vol 3, pg 1, 2018)","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jve.2021.100047_bib21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrmicro975","article-title":"Antivirals and antiviral strategies","volume":"2","author":"De Clercq","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jve.2021.100047_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jve.2021.100047_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.chembiol.2004.01.018","article-title":"Identification of a small molecule that inhibits herpes simplex virus DNA Polymerase subunit interactions and viral replication","volume":"11","author":"Pilger","year":"2004","journal-title":"Chem Biol"},{"key":"10.1016\/j.jve.2021.100047_bib24","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2147\/IDR.S180908","article-title":"Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review","volume":"12","author":"El Helou","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jve.2021.100047_bib25","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1128\/JVI.75.19.9077-9086.2001","article-title":"A Novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products","volume":"75","author":"Buerger","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.jve.2021.100047_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.chembiol.2005.12.002","article-title":"Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase","volume":"13","author":"Loregian","year":"2006","journal-title":"Chem Biol"},{"key":"10.1016\/j.jve.2021.100047_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217578","article-title":"Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency","volume":"14","author":"Bentz","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.jve.2021.100047_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mib.2017.05.008","article-title":"Diversity, classification and evolution of CRISPR-Cas systems","volume":"37","author":"Koonin","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jve.2021.100047_bib29","article-title":"CRISPR\/Cas9-mediated genome editing of herpesviruses limits productive and latent infections","volume":"12","author":"Nelson","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jve.2021.100047_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12985-016-0600-9","article-title":"The mutated tegument protein UL7 attenuates the virulence of herpes simplex virus 1 by reducing the modulation of alpha-4 gene transcription","volume":"13","author":"Xu","year":"2016","journal-title":"Virol J"},{"key":"10.1016\/j.jve.2021.100047_bib31","doi-asserted-by":"crossref","first-page":"23146","DOI":"10.1038\/srep23146","article-title":"Inhibition of HSV-1 replication by gene editing strategy","volume":"6","author":"Roehm","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jve.2021.100047_bib32","first-page":"505","article-title":"Mechanisms of replication of alpha- and betaherpesviruses and their pathogenesis","volume":"102","author":"Rajcani","year":"2001","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.jve.2021.100047_bib33","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1093\/nar\/gkg937","article-title":"Repair of a minimal DNA double-strand break by NHEJ requires DNA-PKcs and is controlled by the ATM\/ATR checkpoint","volume":"31","author":"Kuhne","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jve.2021.100047_bib34","doi-asserted-by":"crossref","first-page":"13157","DOI":"10.1073\/pnas.1410785111","article-title":"RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jve.2021.100047_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virusres.2017.04.019","article-title":"Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR\/Cas9","volume":"244","author":"Yuen","year":"2018","journal-title":"Virus Res"},{"key":"10.1016\/j.jve.2021.100047_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1442-9071.2011.02668.x","article-title":"Small interfering RNA targeting for infected-cell polypeptide 4 inhibits herpes simplex virus type 1 replication in retinal pigment epithelial cells","volume":"40","author":"Duan","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jve.2021.100047_bib37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-4632.2010.04732.x","article-title":"Research of UL54-specific siRNA on herpes simplex virus type II replication","volume":"50","author":"Qing","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jve.2021.100047_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097231","article-title":"Human cytomegalovirus replication is strictly inhibited by siRNAs targeting UL54, UL97 or UL122\/123 gene transcripts","volume":"9","author":"Hamilton","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jve.2021.100047_bib39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5483\/BMBRep.2016.49.4.260","article-title":"Targeted disruption of EBNA1 in EBV-infected cells attenuated cell growth","volume":"49","author":"Noh","year":"2016","journal-title":"BMB Rep"},{"key":"10.1016\/j.jve.2021.100047_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5612","article-title":"Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth","volume":"11","author":"Messick","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jve.2021.100047_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2005.02.010","article-title":"SiRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression","volume":"232","author":"Mei","year":"2006","journal-title":"Canc Lett"},{"key":"10.1016\/j.jve.2021.100047_bib42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2217\/epi.15.55","article-title":"Long noncoding RNAs in human disease: emerging mechanisms and therapeutic strategies","volume":"7","author":"Lalevee","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.jve.2021.100047_bib43","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1073\/pnas.1818290116","article-title":"DNA nanostructures coordinate gene silencing in mature plants","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jve.2021.100047_bib44","article-title":"Carbon nanotube-based DNA vaccine against koi herpesvirus given by intramuscular injection","author":"Hu","year":"2019","journal-title":"Fish Shellfish Immunol"},{"key":"10.1016\/j.jve.2021.100047_bib45","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/emboj\/21.10.2407","article-title":"Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy","volume":"21","author":"Citri","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.jve.2021.100047_bib46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nchembio.597","article-title":"Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins","volume":"7","author":"Neklesa","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jve.2021.100047_bib47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.celrep.2017.06.041","article-title":"Viral activation of heparanase drives pathogenesis of herpes simplex virus-1","volume":"20","author":"Agelidis","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jve.2021.100047_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7985","article-title":"Heparanase is a host enzyme required for herpes simplex virus-1 release from cells","volume":"6","author":"Hadigal","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jve.2021.100047_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jviromet.2017.04.012","article-title":"Development of a robust, higher throughput green fluorescent protein (GFP)-based Epstein-Barr Virus (EBV) micro-neutralization assay","volume":"247","author":"Lin","year":"2017","journal-title":"J Virol Methods"}],"container-title":["Journal of Virus Eradication"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664021000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664021000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:11:47Z","timestamp":1761855107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2055664021000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2055664021000200"],"URL":"https:\/\/doi.org\/10.1016\/j.jve.2021.100047","relation":{},"ISSN":["2055-6640"],"issn-type":[{"value":"2055-6640","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral strategies targeting herpesviruses","name":"articletitle","label":"Article Title"},{"value":"Journal of Virus Eradication","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jve.2021.100047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100047"}}